Endo’s Site shut, 875 American jobs eliminated

Site shut, 875 jobs cut: Endo to close US manufacturing facility

The firm said ceasing operations at the facility – where it makes generic products including pain-relief medications Hydrocodone and Oxycodone, and anti-inflammatory Prednisone – will optimise its network.

“The company completed a comprehensive review of its manufacturing network and made the decision to cease operations and close its manufacturing and distribution facilities in Huntsville,” Endo spokesperson Heather Zoumas-Lubeski told in-PharmaTechnologist.


The closure of the Huntsville facility – to take effect over the next 12 to 18 months – will reduce Endo’s workforce by approximately 865 positions.

Read More…